Differential utilization and localization of ErbB receptor tyrosine kinases in skin compared to normal and malignant keratinocytes
about
Activation of ErbB2 by 2-methyl-1,4-naphthoquinone (menadione) in human keratinocytes: role of EGFR and protein tyrosine phosphatasesTargeted expression of RALT in mouse skin inhibits epidermal growth factor receptor signalling and generates a Waved-like phenotype.Neuregulin3 alters cell fate in the epidermis and mammary glandDifferential ErbB1 signaling in squamous cell versus basal cell carcinoma of the skinEvidence for altered Wnt signaling in psoriatic skin.Dual inhibition of both the epidermal growth factor receptor and erbB2 effectively inhibits the promotion of skin tumors during two-stage carcinogenesis.Resveratrol induces long-lasting IL-8 expression and peculiar EGFR activation/distribution in human keratinocytes: mechanisms and implications for skin administration.Amphiregulin carboxy-terminal domain is required for autocrine keratinocyte growth.EGFR and IL-1 signaling synergistically promote keratinocyte antimicrobial defenses in a differentiation-dependent mannerBlockade of the EGF receptor induces a deranged chemokine expression in keratinocytes leading to enhanced skin inflammation.New advances on the functions of epidermal growth factor receptor and ceramides in skin cell differentiation, disorders and cancers.Heparin-binding EGF-like growth factor promotes epithelial-mesenchymal transition in human keratinocytes.Beyond wavy hairs: the epidermal growth factor receptor and its ligands in skin biology and pathology.Neuregulin-1 modulates hippocampal gamma oscillations: implications for schizophrenia.Desmoglein 1-dependent suppression of EGFR signaling promotes epidermal differentiation and morphogenesisMetalloproteinase-mediated, context-dependent function of amphiregulin and HB-EGF in human keratinocytes and skin.Autocrine extracellular signal-regulated kinase (ERK) activation in normal human keratinocytes: metalloproteinase-mediated release of amphiregulin triggers signaling from ErbB1 to ERK.Growth factor signaling pathways as targets for prevention of epithelial carcinogenesis.EGFR-ras-raf signaling in epidermal stem cells: roles in hair follicle development, regeneration, tissue remodeling and epidermal cancers.An inhibitor of the EGF receptor family blocks myeloma cell growth factor activity of HB-EGF and potentiates dexamethasone or anti-IL-6 antibody-induced apoptosis.EGFR/ERBB receptors differentially modulate sebaceous lipogenesis.Role of EGF receptor ligands in TCDD-induced EGFR down-regulation and cellular proliferationZinc finger transcription factors designed for bispecific coregulation of ErbB2 and ErbB3 receptors: insights into ErbB receptor biology.Comparative analysis of the expression of ERBIN and Erb-B2 in normal human skin and cutaneous carcinomas.Epidermal growth factor receptor dimerization status determines skin toxicity to HER-kinase targeted therapies.Metalloproteinases stimulate ErbB-dependent ERK signaling in human skin organ culture.Immunohistochemical expression patterns of the HER4 receptors in normal mucosa and in laryngeal squamous cell carcinomas: antioncogenic significance of the HER4 protein in laryngeal squamous cell carcinoma.Differential activity of 2-methylene-19-nor vitamin D analogs on growth factor gene expression in rhino mouse skin and comparison to all-trans retinoic acid.An ErbB receptor-mediated AP-1 regulatory network is modulated by STAT3 and c-MYC during calcium-dependent keratinocyte differentiation.Neuregulin 1 represses limbic epileptogenesis through ErbB4 in parvalbumin-expressing interneurons.Effects of HB-EGF and epiregulin on wound healing of gingival cells in vitro.
P2860
Q24306579-31BFC2E3-1E57-4619-B05A-10C496505C84Q24539106-C7EA1AE0-508C-45B5-A6AD-2C2418407175Q24681926-58BE9686-D99A-4188-B447-C9ABC9F70C5CQ24683791-45F4EBD7-B146-4BD1-B769-1079026CD4DFQ33915311-104AF528-88AA-474C-90D8-789FC3721884Q34130669-32369217-9F17-4B6A-AA0D-EE591545FF2DQ34635356-9BA96C9C-208F-4407-B74F-ED167F1BBA76Q34773509-AF06864D-8862-44C5-9D72-1B7876509A13Q34981103-6AF63405-34FD-4604-BCEB-C6042F1DC497Q35791607-8F093E0E-F4B2-43B2-8CE5-A12D913F1505Q35838744-BE597270-8C82-4CC7-B675-7E55F7CED111Q36177166-CDFC9766-496A-49EB-AE44-05D19AAC69A4Q36734845-DCD69AF1-C479-4535-8DDC-A346CF2AB320Q37090102-4A2767DB-CD47-49AB-8AB7-CAFCE66018F0Q37267606-AC62EBCE-ADAA-4C2B-AF85-856D2B87320EQ37480932-6036568F-5C29-48C5-A9ED-77E1323184C3Q37497430-2A2BF64A-DE5F-4607-AA51-5CC35721B748Q37774602-5B92536B-48E4-45FA-9615-F3F3548127B2Q38144765-B06BB90B-7CC7-48D4-A331-A248E04710CFQ38518964-C7529798-F3FA-4399-B395-8420CB5CDA5CQ38885235-4FDAACA3-72B0-4514-9568-79534CC76410Q39819174-3AF56099-EDC0-49F1-8D09-3C1F1D386539Q40366552-FBDB6258-C6A8-4DA4-A6F1-DC4307CC7325Q40411278-14180225-64A7-4C3C-92D3-56737B744B6EQ43200061-8F7CF5D2-6EF1-4B89-9DAA-4C5C08294485Q43997250-EF4E3D47-D773-4C01-9F54-314526357491Q45899687-067AD6C2-B8BA-47B3-98F3-B80A8244321CQ47123884-9C3EE5A8-7D85-43F8-A273-1D6289CEC228Q48021975-3A96C667-6010-46C6-A69B-11702FF78FD9Q48204966-F99025A6-2EE0-40A2-A73B-4E479F1D46A9Q53414702-8A94C1FA-5FF9-42B9-AB09-1E3B13289DC1
P2860
Differential utilization and localization of ErbB receptor tyrosine kinases in skin compared to normal and malignant keratinocytes
description
2001 nî lūn-bûn
@nan
2001 թուականին հրատարակուած գիտական յօդուած
@hyw
2001 թվականին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Differential utilization and l ...... al and malignant keratinocytes
@ast
Differential utilization and l ...... al and malignant keratinocytes
@en
Differential utilization and l ...... al and malignant keratinocytes
@nl
type
label
Differential utilization and l ...... al and malignant keratinocytes
@ast
Differential utilization and l ...... al and malignant keratinocytes
@en
Differential utilization and l ...... al and malignant keratinocytes
@nl
prefLabel
Differential utilization and l ...... al and malignant keratinocytes
@ast
Differential utilization and l ...... al and malignant keratinocytes
@en
Differential utilization and l ...... al and malignant keratinocytes
@nl
P2093
P2860
P1433
P1476
Differential utilization and l ...... al and malignant keratinocytes
@en
P2093
J F Wiesen
W R Leopold
P2860
P304
P356
10.1038/SJ.NEO.7900170
10.1038/SJ/NEO/7900170
P407
P577
2001-07-01T00:00:00Z